Search

everythinglearnresearchcommunity

for

Search:↓

Tyrosine kinase inhibitors for endocrine tumors often cause skin issues, requiring early management and treatment adjustments.

Vemurafenib therapy can cause hair loss, but clobetasol propionate foam can help regrow hair.

TAp63 and NRF2 work together to manage oxidative stress, preventing premature aging and aiding skin functions.

ALRN-6924 may prevent hair loss caused by chemotherapy.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Fluorescent proteins help visualize and understand tumor blood vessel growth.

Human hair follicle stem cells improve ovarian function in mice with damaged ovaries.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

Certain plasma proteins are linked to prostate cancer risk and could help in early detection and treatment.

PBX1 helps reduce aging and cell death in hair follicle stem cells by decreasing DNA damage, not by improving DNA repair.

Phospholipase C-δ1 is crucial for normal hair development.

Immortalized human dermal papilla cells were created that grow better and can still help form hair.

Tofacitinib may be an effective and safe treatment for adolescent alopecia areata.

Temporary ROS production in cultured human hair follicles promotes growth and stem cell activation.

Genetic testing for cancer risk can lead to early and life-saving treatments in people without symptoms.

GKLF/KLF4 and Sp1 control Keratin 19 gene activity, influencing cancer-related changes.

Trametinib can effectively treat severe kaposiform lymphangiomatosis when other treatments fail.

A new treatment using nanoliposomes can improve hair regrowth in androgenetic alopecia.

TP0427736 may help treat hair loss by blocking a specific protein and promoting hair growth.

PBX1 reduces aging and cell death in stem cells by boosting SIRT1 and lowering PARP1.

FOL-026 peptide can help repair blood vessels and promote growth, offering potential treatment for vascular diseases.

Topical IKKα inhibitors may help prevent CCS tumours.

A low dose of rapamycin increases inner ear hair cell creation by boosting SOX2+ cell numbers.

Androgens increase a growth factor in hair cells by creating reactive oxygen species, and antioxidants might help treat hair loss.

The treatment improved survival and controlled cancer spread but required managing side effects like rashes.

Blocking EGFR can cause skin inflammation by disrupting IL-1 signaling.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

The drug combination was safe and showed promise in treating advanced tumors.

Laser treatments are the most effective for porokeratotic adnexal ostial nevus.